Follow the Syra Health Corp share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €10.4m. The latest transaction was disclosed on 3 February 2026 (Attribution). Among the most active insiders: Allam Sandeep. The full history is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€8,799
12 ops.
Buy Volume
n/a
n/a
Sell Volume
49Σ signal
Buys €8,799n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,643 of 29,063 companies
23.8
score / 100
Value
20
Quality
27
FCF yld-4.3%
Earn yld-8.7%
EV/EBITDA·
ROE-7.6%
Gross mgn34%
Net mgn-12%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
294 shares@ US$1.317.7% of flowClass A Common StockSEC:0001493152-23-046134:8
Canonical exit: 13 Mar 2024 (T+90)
13 of 13 declarations
Acerca de Syra Health Corp
Syra Health Corp es una empresa que cotiza en el mercado XNAS, especializada en el sector de la salud. Se enfoca en desarrollar soluciones innovadoras para mejorar los servicios de atención médica.